Month: July 2022

Who should take Paxlovid?

Who should take Paxlovid?

Paxlovid is a drug that is approved under emergency use for the treatment of Covid-19 infection. However, this drug is not for everyone who has the Covid-19 infection because it has quite a number of side effects. At the same time, this drug has not fully completed the necessary clinical trials and is not approved by the US FDA.

So, if not for everyone, then who should take Paxlovid?

Click here for the details.

Criteria for second Covid-19 booster shot

Criteria for second Covid-19 booster shot

  1. Those aged 60 and above can receive a second Covid-19 vaccine booster dose voluntarily four to six months after their first booster.
  2. For people aged 18 to 59, they can get their second booster shot if they have chronic diseases and after consulting a medical practitioner. This includes those who are at clinical risk of severe disease such as chronic heart, lung, kidney, liver disease, etc.
  3. Those aged between 12 and 17 could also be offered a first booster dose after receiving the primary dose injection following discussion with a registered medical practitioner, or if they were at clinical risk of severe disease.
  4. Healthcare workers, regardless of age or health status, and those who require additional doses for travel purposes, are also eligible.
Criteria for the initiation of Paxlovid treatment

Criteria for the initiation of Paxlovid treatment

Paxlovid antiviral therapy is effective for high-risk COVID-19 patients who have mild to moderate symptoms to prevent the disease from worsening.

However, the antiviral treatment has to be initiated within five (5) days from the onset of symptoms.

Therefore, if you are in a high-risk group, get a medical assessment early to determine your eligibility to take Paxlovid.